{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T08:55:15Z","timestamp":1762678515956,"version":"build-2065373602"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01 DA03926"],"award-info":[{"award-number":["U01 DA03926"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>HIV pre-exposure prophylaxis (PrEP) use has been linked with increases in sexually transmitted infection (STI) incidence. Despite efforts to expand PrEP uptake among young Black and Hispanic men who have sex with men (YBHMSM), little research has been done to understand the impact of PrEP on STI incidence within these communities. We examine the effect of PrEP use on gonorrhea and chlamydia (NG\/CT) incidence, condom use, and external STI testing (ie, outside of study visits).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a longitudinal cohort of HIV-negative YBHMSM (ages 16\u201324 years), we modeled the effect of PrEP use on study-external STI testing and number of condomless sex partners during the following 6 months using mixed-effects generalized linear models. We modeled the effect of PrEP use on NG\/CT incidence using time-updated proportional hazard regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While on PrEP compared with periods not on PrEP, participants reported on average 2.51 (adjusted beta; 95% CI, 1.51\u20133.51; P &amp;lt; .001) more condomless sex partners and were 2.28 (adjusted OR; 95% CI, 1.48\u20133.52; P &amp;lt; .001) times as likely to report study-external STI testing during the following 6 months. NG\/CT incidence did not increase (adjusted HR, 0.75; 95% CI, 0.45\u20131.27; P = .286) while on PrEP compared with not on PrEP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Condomless sex increased with PrEP use; however, its potential to elevate STI acquisition or prolonged duration of infection may be mitigated by PrEP-associated routine testing. Efforts to expand PrEP uptake among YBHMSM appear unlikely to exacerbate the STI epidemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf605","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T08:50:47Z","timestamp":1762678247000},"source":"Crossref","is-referenced-by-count":0,"title":["HIV Pre-exposure Prophylaxis Does Not Increase Gonorrhea and Chlamydia Incidence in Young Black and Hispanic Men who Have Sex With Men: An Observational Cohort Study"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6024-9508","authenticated-orcid":false,"given":"Octavio C","family":"Mesner","sequence":"first","affiliation":[{"name":"Brown School, Washington University , St Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishabh","family":"Jain","sequence":"additional","affiliation":[{"name":"Brown School, Washington University , St Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0843-1414","authenticated-orcid":false,"given":"Aditi","family":"Ramakrishnan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine , St Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick D","family":"Matthews","sequence":"additional","affiliation":[{"name":"Health Behavior, University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy T","family":"Goldbach","sequence":"additional","affiliation":[{"name":"Brown School, Washington University , St Louis, Missouri ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2025110903504158900_ofaf605-B1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110903504158900_ofaf605-B2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"key":"2025110903504158900_ofaf605-B3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"key":"2025110903504158900_ofaf605-B4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12879-020-4831-4","article-title":"STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany","volume":"20","author":"Jansen","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025110903504158900_ofaf605-B5","doi-asserted-by":"crossref","first-page":"e0245925","DOI":"10.1371\/journal.pone.0245925","article-title":"Low use of condom and high STI incidence among men who have sex with men in PrEP programs","volume":"16","author":"Ayerdi Aguirrebengoa","year":"2021","journal-title":"PLoS One"},{"key":"2025110903504158900_ofaf605-B6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/QAD.0000000000003187","article-title":"Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis","volume":"36","author":"Zeggagh","year":"2022","journal-title":"AIDS"},{"key":"2025110903504158900_ofaf605-B7","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3018(24)00211-X","article-title":"Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study","volume":"11","author":"Torres Silva","year":"2024","journal-title":"Lancet HIV"},{"key":"2025110903504158900_ofaf605-B8","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jama.2019.2947","article-title":"Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection","volume":"321","author":"Traeger","year":"2019","journal-title":"JAMA"},{"key":"2025110903504158900_ofaf605-B9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QAD.0000000000001718","article-title":"Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV","volume":"32","author":"Nguyen","year":"2018","journal-title":"AIDS"},{"key":"2025110903504158900_ofaf605-B10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/ciz552","article-title":"Human immunodeficiency virus pre-exposure prophylaxis and increased incidence of sexually transmitted infections in the United States","volume":"70","author":"Serpa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025110903504158900_ofaf605-B11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(21)00395-0","article-title":"Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses","volume":"397","author":"Sullivan","year":"2021","journal-title":"Lancet"},{"key":"2025110903504158900_ofaf605-B12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"2025110903504158900_ofaf605-B13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025110903504158900_ofaf605-B14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cid\/ciz894","article-title":"Pre-exposure prophylaxis uptake and discontinuation among young Black men who have sex with men in Atlanta, Georgia: a prospective cohort study","volume":"71","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025110903504158900_ofaf605-B15","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.amepre.2021.05.027","article-title":"Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic\/Latino individuals in the U.S","volume":"61","author":"Bonacci","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025110903504158900_ofaf605-B16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","article-title":"Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting","volume":"23","author":"Monta\u00f1o","year":"2019","journal-title":"AIDS Behav"},{"key":"2025110903504158900_ofaf605-B17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/cid\/cix439","article-title":"Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study","volume":"65","author":"Jenness","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025110903504158900_ofaf605-B18","doi-asserted-by":"crossref","first-page":"2382552","DOI":"10.1080\/25787489.2024.2382552","article-title":"Factors driving decisions in the use of HIV pre-exposure prophylaxis: a real-world study in the United States","volume":"25","author":"Whiteside","year":"2024","journal-title":"HIV Res Clin Pract"},{"key":"2025110903504158900_ofaf605-B19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/sextrans-2021-055381","article-title":"Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men","volume":"99","author":"Hart","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2025110903504158900_ofaf605-B20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciy182","article-title":"Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis","volume":"67","author":"Traeger","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025110903504158900_ofaf605-B21","doi-asserted-by":"crossref","first-page":"e10738","DOI":"10.2196\/10738","article-title":"A focus on the HIV care continuum through the Healthy Young Men's Cohort Study: protocol for a mixed-methods study","volume":"8","author":"Kipke","year":"2019","journal-title":"JMIR Res Protoc"},{"key":"2025110903504158900_ofaf605-B22","author":"Centers for Disease Control and Prevention"},{"key":"2025110903504158900_ofaf605-B23","doi-asserted-by":"crossref","first-page":"e2261","DOI":"10.1093\/cid\/ciaa1033","article-title":"Gaps in sexually transmitted infection screening among men who have sex with men in pre-exposure prophylaxis (PrEP) care in the United States","volume":"73","author":"Chandra","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025110903504158900_ofaf605-B24","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad488","article-title":"Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections","author":"Traeger","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf605\/65051823\/ofaf605.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/11\/ofaf605\/65051823\/ofaf605.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T08:50:50Z","timestamp":1762678250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf605\/8307628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf605","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]},"article-number":"ofaf605"}}